NCT07317882

Brief Summary

Background: Heart Failure (HF) is one of the most prevalent pathologies in Western countries, representing a significant percentage of their healthcare expenditure. Much of the success of specialised programmes for the control and treatment of this pathology is achieved within Heart Failure Units. These programmes are based on enhancing patients' capacity to perform effective self-care. Self-care in heart failure involves several aspects: maintaining healthy lifestyle habits, monitoring signs and symptoms of decompensation, controlling blood pressure, heart rate, and body weight, and the ability to manage potential decompensations either autonomously or by seeking available healthcare services. Heart failure units carry out structured therapeutic education for these patients through individualized, face-to-face educational interventions upon admission to the unit, placing special emphasis on training patients and their caregivers in effective self-care. However, studies show that the level of self-care among HF patients remains low. Furthermore, the new healthcare reality following the pandemic situation necessitates the search for strategies that facilitate better time management while improving the self-care capacity of HF patients. Within this clinical context, it is necessary to seek alternatives that allow for the provision of adequate quality of care while overcoming the obstacles imposed by the current situation. Objective: The objective of the study is to evaluate the effectiveness of a telematics-based educational intervention, in addition to the standard standardised educational intervention, in self-care in patients in the Heart Failure Unit six months after admission. Methodology: A randomised clinical trial design with parallel groups (intervention and control) will be applied. The study sample, consisting of 50 patients in each group, will be recruited from patients treated in the Heart Failure Unit of the University Hospital. All patients and their caregivers (if applicable) in both groups will receive the same individualised educational intervention. The patients assigned to the intervention group will also receive a telematics-based educational intervention through video call through the WhatsApp messaging application three months after the initial face-to-face intervention. The study variables will include sociodemographic and physiological data, adherence to pharmacological treatment, immunisations, dietary assessment, physical exercise assessment, number and management of decompensations, self-care levels and quality of life. After six months in the heart failure unit, all patients in both groups will be reassessed using the same instruments and the statistical differences between the groups will be analysed. The primary outcome variable will be the level of self-care, measured by the European Heart Failure Self-care Behaviour Scale.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable heart-failure

Timeline
1mo left

Started Jan 2025

Shorter than P25 for not_applicable heart-failure

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Jan 2025Jun 2026

Study Start

First participant enrolled

January 7, 2025

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

December 19, 2025

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 5, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 7, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 7, 2026

Expected
Last Updated

January 8, 2026

Status Verified

December 1, 2025

Enrollment Period

1.2 years

First QC Date

December 19, 2025

Last Update Submit

January 5, 2026

Conditions

Keywords

Heart failuredigital healthself care

Outcome Measures

Primary Outcomes (1)

  • European Heart Failure Self-Care Behaviour Scale

    It consists of a 12-item self-administered questionnaire that addresses different aspects of patient self-care. It is scored using a Likert scale from 1 (strongly agree/always) to 5 (strongly disagree/never). This allows for the classification of the overall self-care level within the following ranges: low (44-60), medium (28-43), and high (12-27).

    From enrollment to the end of intervention at 6 months

Study Arms (2)

Digital health

EXPERIMENTAL
Behavioral: Digital health

Control

NO INTERVENTION

Interventions

Digital healthBEHAVIORAL

Education through mHealth

Digital health

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults over 18 years of age.
  • Clinical diagnosis of heart failure class II, III and IV.
  • Ejection fraction less than or equal to 35%.
  • Those who have a smartphone that allows video calls.

You may not qualify if:

  • Patients with impaired cognitive ability, meaning they cannot follow basic self-care and education guidelines.
  • Patients with acute heart failure that can be resolved by treating the underlying cause.
  • Patients with high comorbidity, where non-cardiac conditions pose a greater risk and have a worse prognosis than heart failure itself.
  • Patients enrolled in any other clinical trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Jerez

Cadiz, Cádiz, 11009, Spain

Location

MeSH Terms

Conditions

Heart Failure

Interventions

Digital Health

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Delivery of Health CarePatient Care ManagementHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Doctor of Medicine

Study Record Dates

First Submitted

December 19, 2025

First Posted

January 5, 2026

Study Start

January 7, 2025

Primary Completion

March 7, 2026

Study Completion (Estimated)

June 7, 2026

Last Updated

January 8, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

Locations